Detalhe da pesquisa
1.
Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract.
Blood Adv
; 8(9): 2074-2084, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38471063
2.
Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia.
Clin Cancer Res
; 29(11): 2034-2042, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37014667
3.
Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignancies.
Blood Adv
; 6(22): 5857-5865, 2022 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150050